Abstract: A tamper-indicating and child resistant cap and container assembly, comprising a cap comprising: a cap top wall; a cap skirt having an inner wall which is at least partially threaded, and an outer wall having at least one squeezing location; at least one tamper-indicating band frangibly connected to a free end of the cap and having defined therethrough an opening; at least one tongue extending from the free end of the cap skirt which circumferentially spaced from the at least one squeezing location. The container has an open end and a neck, an outer wall of the neck being at least partially threaded and configured to cooperate with the at least partially threaded inner wall of the cap; and at least one protrusion extending from the outer wall of the container neck and configured to be received in the opening of the at least one tamper-indicating band.

Abstract: A method of treatment for treating, preventing, inhibiting or reducing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or for restoring tissue adversely affected by said disease, in a subject, includes administering to a subject in need of such treatment an effective amount of a composition including a peptide agent including amino acid sequence LKKTET or LKKTNT, a conservative variant thereof, or a peptide agent that stimulates production of an LKKTET or LKKTNT peptide, or a conservative variant thereof, in the tissue.

Abstract: A method of treatment for treating, inhibiting, reducing or at least partly preventing respiratory or pulmonary microbial infection or gastrointestinal disorder of tissue of a subject, includes administering to a subject an effective amount of a composition including a polypeptide including thymosin ?4 (TB4), an isoform of TB4, an N-terminal variant of TB4, a C-terminal variant of TB4, LKKTET or a conservative variant thereof, LKKTNT or a conservative variant thereof, TB4 sulfoxide, TB4ala, T?9, T?10, T?11, T?12, T?13, T?14, T?15, gelsolin, vitamin D binding protein (DBP), profilin, cofilin, adsevertin, propomyosin, fincilin, depactin, Dnasel, vilin, fragmin, severin, capping protein, ?-actinin, acumentin or a combination thereof, so as to inhibit the infection or disorder.

Abstract: Microbial infections including anthrax infection, and gastrointestinal disorders, are treated or prevented by administration of an actin-sequestering peptide including amino acid sequence LKKTET, such as Thymosin ?4, an isoform of Thymosin ?4, oxidized Thymosin ?4, or T?4 sulfoxide.

Abstract: Inflammation or damage associated with myocardial events is treated or prevented by administration of an angiogenesis-inducing, anti-inflammatory peptide such as Thymosin &bgr;4, an isoform of Thymosin &bgr;4 or oxidized Thymosin &bgr;4.

Abstract: Blisters, sores or skin degradation associated with Epidermolysis Bullosa is treated or prevented by administration of an actin-sequestering peptide such as Thymosin &bgr;4, an isoform of Thymosin &bgr;4 or oxidized Thymosin &bgr;4.